Aging-related brain diseases consist of a number of important neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's diseases, all of which have become more prevalent as the life expectancy of humans is prolonged. Age-dependent brain disorders are associated with both environmental insults and genetic mutations. For those brain disorders that are inherited, gene editing is an important tool for establishing animal models to investigate the pathogenesis of disease and identify effective treatments. Here we focus on the tools for gene editing, especially CRISPR/Cas9, and discuss their application for generating animal models that can recapitulate the brain pathology seen in human diseases. We also highlight the advantages and disadvantages of establishing genetically modified animal models. Finally, we discuss recent findings to resolve technical issues related to the use of CRISPR/Cas9 for generating animal models of brain diseases.
Introduction
A number of important brain disorders are associated with aging, and their prevalence continues to climb as the life expectancy of humans is extended. These brain disorders include Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and frontotemporal dementia (FTD). The common features of these neurological diseases are late-onset neurological symptoms and degeneration that preferentially affects neuronal cells in the brain. Although most cases of neurodegenerative diseases are sporadic, a number of genetic mutations are known to cause agedependent neurodegeneration. For example, In HD, an expanded CAG repeat (> 36 repeats) in the huntingtin gene causes neurodegeneration in an autosomal dominant manner (Gusella et al., 1993) . In AD, mutations in the genes for presenilin, amyloid precursor protein (APP), or tau contribute critically to selective neurodegeneration (Hutton and Hardy, 1997; Kang et al., 1987; Alzheimer et al., 1995) . In PD, mutations in alpha-synuclein or Parkin and PINK1 can cause autosomal dominant or recessive neurodegeneration (Polymeropoulos et al., 1997; Dodson and Guo, 2007) . Familial ALS can be caused by mutations in one of at least 32 known genetic loci, including superoxide dismutase 1 (SOD1), TAR DNA-binding protein 43 (TDP-43), fused in sarcoma (FUS), and C9ORF72 (Joyce et al., 2011; Neumann et al., 2006; DeJesus-Hernandez et al., 2011) . Identification of the genetic mutations in these diseases has enabled the generation of a variety of animal models via genome modifications.
Although genetically modified animal models have been widely used to investigate the mechanisms of different brain disorders and to develop therapeutic strategies, the ways to produce animal models determine the nature of the disease models and their utility for different purposes. In general, genetically modified animals models can be classified as transgenic or gene-targeted animal models. In transgenic models, the transgene is randomly inserted into the genome as an exogenous gene and is expressed under the exogenous promoter. In gene-targeted animal models, the specific locus or region of an endogenous gene is altered to mimic a specific genetic mutation in humans. Obviously, gene-targeted (knock-in or knockout) animal models are intended to recapitulate the same genetic defects seen in human beings and are expected to more faithfully replicate patient pathology. In this review, we focus on genomic editing tools that enable the generation of animal models of brain diseases by modifying endogenous genomes.
Genomic editing tools
The classic method for manipulating the endogenous genome involves use of a gene targeting vector to replace a specific region of endogenous genome via homologous recombination. This method relies on embryonic stem (ES) cells that allow for gene targeting in vitro, and then transplantation in vivo for differentiation into different types of cell. Because mouse ES cells are available, this approach has been widely used to generate germline knockout or knock-in mouse models. 
